The idea that a bone-stock American supercar can dip deep into the 9-second zone still sounds unreal—but it just happened. Brooks from DragTimes piloted a stock ...

This fifth-generation Camaro SS was recently treated to a new ECU, and it responded by laying down nearly 2,000 horsepower.

Each of the four engines pulled for dyno inspection and taken to Robert Yates Racing Engines following the Snowball Derby ...

General Motors made V8s with 5.3-liter and 6.2-liter displacements. While they're under the same brand name, there are a few ...

Many soldiers at Army commands in SA likely moving to Fort Bragg IRS whistleblowers release book on Hunter Biden case: "We were vindicated" An attack on all American tech platforms: Trump admin ...

After months of troubleshooting, the Jaguar XJC V12 finally hits the dyno. With a modern Emerald ECU, larger throttle bodies, and a refined exhaust, power jumps from 285 to nearly 350hp. The result: ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Shares of Zscaler, Inc. (NASDAQ: ZS) are trading lower Wednesday after the cloud security company reported first-quarter earnings results. What To Know: Zscaler reported revenue of $788.1 million in ...

StubHub Holdings Inc.‘s initial public offering paperwork misrepresented its free cash flow, leading to a stock decline after its third-quarter financial results were announced, an investor’s proposed ...

Shares of Keysight Technologies (KEYS) jumped about 14% premarket on Tuesday after fourth-quarter results and guidance surpassed estimates and drew largely positive reactions from analysts. Citi kept ...

Q3 Highlights: Zoom posted revenue of $1.23 billion for the third quarter, beating the consensus estimate of $1.21 billion. The company reported third-quarter adjusted earnings of $1.52 per share, ...

Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug which had previously showed to be ineffective in another trial. The ...